KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Debt Ratio (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Debt Ratio for 13 consecutive years, with 0.12 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Debt Ratio changed N/A year-over-year to 0.12, compared with a TTM value of 0.12 through Jun 2025, changed N/A, and an annual FY2024 reading of 0.12, changed N/A over the prior year.
  • Debt Ratio was 0.12 for Q2 2025 at Travere Therapeutics, down from 0.13 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.14 in Q3 2024 and bottomed at 0.01 in Q1 2023.
  • Average Debt Ratio over 5 years is 0.05, with a median of 0.01 recorded in 2022.
  • The sharpest move saw Debt Ratio plummeted 66.74% in 2021, then rose 9.23% in 2022.
  • Year by year, Debt Ratio stood at 0.01 in 2021, then rose by 9.23% to 0.01 in 2022, then dropped by 9.97% to 0.01 in 2023, then surged by 1133.73% to 0.12 in 2024, then increased by 7.24% to 0.12 in 2025.
  • Business Quant data shows Debt Ratio for TVTX at 0.12 in Q2 2025, 0.13 in Q1 2025, and 0.12 in Q4 2024.